Quick Answer
Krystal Biotech, Inc. reported Common Stock Shares Outstanding of 29.19 million shares for the year ending 2025.
- Krystal Biotech, Inc. showed an increase of +1.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Krystal Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2016 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: 10.24 million shares | Q4 2017: 10.31 million shares | Q1 2018: 10.31 million shares | Q2 2018: 10.35 million shares | Q3 2018: 10.98 million shares | Q1 2019: 14.44 million shares | Q2 2019: 16.95 million shares | Q3 2019: 17.31 million shares | Q1 2020: 17.37 million shares | Q2 2020: 19.66 million shares | Q3 2020: 19.71 million shares | Q1 2021: 22.20 million shares | Q2 2021: 22.21 million shares | Q3 2021: 22.24 million shares | Q2 2022: 25.66 million shares | Q3 2022: 25.71 million shares | Q1 2023: 25.80 million shares | Q2 2023: 27.97 million shares | Q3 2023: 28.19 million shares | Q1 2024: 28.53 million shares | Q2 2024: 28.71 million shares | Q3 2024: 28.76 million shares | Q1 2025: 28.90 million shares | Q2 2025: 28.93 million shares | Q3 2025: 28.98 million shares.
- Historical annual values: Fiscal year 2025: 29.19 million shares | Fiscal year 2024: 28.79 million shares | Fiscal year 2023: 28.24 million shares | Fiscal year 2022: 25.76 million shares | Fiscal year 2021: 25.21 million shares | Fiscal year 2020: 19.71 million shares | Fiscal year 2019: 17.35 million shares | Fiscal year 2018: 14.43 million shares | Fiscal year 2017: 10.31 million shares | Fiscal year 2017: 3.49 million shares | Fiscal year 2016: 0 shares.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: